State Street’s Acer Therapeutics Inc ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-53,035
| Closed | -$43.8K | – | 4557 |
|
|
2023
Q3 | $43.8K | Hold |
53,035
| – | – | ﹤0.01% | 4317 |
|
|
2023
Q2 | $49K | Sell |
53,035
-1,890
| -3% | -$1.68K | ﹤0.01% | 4422 |
|
|
2023
Q1 | $41.7K | Hold |
54,925
| – | – | ﹤0.01% | 4548 |
|
|
2022
Q4 | $138K | Buy |
54,925
+34,700
| +172% | +$59.6K | ﹤0.01% | 4254 |
|
|
2022
Q3 | $28K | Sell |
20,225
-3,240
| -14% | -$4.69K | ﹤0.01% | 4781 |
|
|
2022
Q2 | $30K | Sell |
23,465
-2,100
| -8% | -$4.4K | ﹤0.01% | 4820 |
|
|
2022
Q1 | $74K | Buy |
25,565
+600
| +2% | +$1.45K | ﹤0.01% | 4716 |
|
|
2021
Q4 | $57K | Hold |
24,965
| – | – | ﹤0.01% | 4679 |
|
|
2021
Q3 | $64K | Hold |
24,965
| – | – | ﹤0.01% | 4622 |
|
|
2021
Q2 | $71K | Buy |
+24,965
| New | +$71.8K | ﹤0.01% | 4405 |
|
|
2020
Q4 | – | Sell |
-12,849
| Closed | -$37K | – | 3917 |
|
|
2020
Q3 | $37K | Sell |
12,849
-4,410
| -26% | -$14.3K | ﹤0.01% | 3773 |
|
|
2020
Q2 | $59K | Sell |
17,259
-119,476
| -87% | -$337K | ﹤0.01% | 3699 |
|
|
2020
Q1 | $272K | Buy |
136,735
+25,156
| +23% | +$92.2K | ﹤0.01% | 3541 |
|
|
2019
Q4 | $447K | Sell |
111,579
-38,887
| -26% | -$132K | ﹤0.01% | 3540 |
|
|
2019
Q3 | $480K | Buy |
150,466
+49,730
| +49% | +$146K | ﹤0.01% | 3515 |
|
|
2019
Q2 | $393K | Buy |
+100,736
| New | +$1.92M | ﹤0.01% | 3540 |
|
Other funds holding ACER
State Street's ACER Position: Q4 2023 in Review
State Street sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 53,035 shares — an estimated $43.8K sold.
State Street first reported a position in ACER in Q2 2019 and held it in 16 quarters. The position peaked at $480K in Q3 2019. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.
- State Street reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
- State Street sold 53,035 Acer Therapeutics Inc shares in Q4 2023, an estimated $43.8K.
- State Street first reported a position in Acer Therapeutics Inc in Q2 2019 and held it in 16 quarters.
- State Street's Acer Therapeutics Inc position peaked at $480K in Q3 2019.
- 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.
Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.